Development of Clinical Laser Septoplasty System

Information

  • Research Project
  • 8981219
  • ApplicationId
    8981219
  • Core Project Number
    R43DE025554
  • Full Project Number
    1R43DE025554-01
  • Serial Number
    025554
  • FOA Number
    PA-14-071
  • Sub Project Id
  • Project Start Date
    9/1/2015 - 9 years ago
  • Project End Date
    8/31/2016 - 8 years ago
  • Program Officer Name
    LUNSFORD, DWAYNE
  • Budget Start Date
    9/1/2015 - 9 years ago
  • Budget End Date
    8/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/24/2015 - 9 years ago
Organizations

Development of Clinical Laser Septoplasty System

? DESCRIPTION (provided by applicant): Approximately, 1 in 124 people, or 2.2 million people in USA suffer from deviated septum and related nasal obstruction. Nasal septoplasty, a surgical approach is reserved as the last resort for patients with severe symptoms so patients only opt to receive septoplasty as part of a cosmetic rhinoplasty. Those with less severe symptoms would stick with long-term pharmacologic treatments, which ultimately overburden the current health care system. It is estimated that at least 250,000 septoplasties are performed annually, ranking in the top ten of the most common surgical procedures performed in the U.S. Recently, laser cartilage reshaping (LCR) has been demonstrated clinically as a minimally invasive alternative procedure. Despite the simplicity of the procedure, LCR has not been widely adopted by the clinicians due to the following barriers: (a) lack of availability of cost-effective laser system fr cartilage reshaping, and (b) heat related tissue damage from lack of proper cooling method. Our ultimate goal is to address these barriers by delivering a safe and user-friendly laser therapy system for routine septoplasty in cost-effective manner. In this Phase 1 SBIR proposal, we will build and test a clinic-ready prototype new laser system and a probe with tissue cooling feature for septoplasty cartilage re-shaping. Upon successful completion, the device will be used to carry out a first pilot human trial in future Phase 2 proposals.

IC Name
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
  • Activity
    R43
  • Administering IC
    DE
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    193588
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    121
  • Ed Inst. Type
  • Funding ICs
    NIDCR:193588\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    RESHAPE LIFESCIENCES, LLC
  • Organization Department
  • Organization DUNS
    079604423
  • Organization City
    LAGUNA NIGUEL
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    926771321
  • Organization District
    UNITED STATES